Pedro Sánchez Rovira-rekin lankidetzan egindako argitalpenak (5)

2023

  1. Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients

    Metabolomics, Vol. 19, Núm. 7

2022

  1. Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

    Molecular Oncology, Vol. 16, Núm. 14, pp. 2658-2671

  2. TFG-β Nuclear Staining as a Potential Relapse Risk Factor in Early-Stage Non-Small-Cell Lung Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 22

2021

  1. Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission

    Medicine, Vol. 100, Núm. 29, pp. e26533

  2. Human plasma metabolomics for biomarker discovery: Targeting the molecular subtypes in breast cancer

    Cancers, Vol. 13, Núm. 1, pp. 1-18